In 2022, chronic lower respiratory disease was the sixth highest cause of death in the U.S., according to results published ...

Boehringer Ingelheim has cemented the potential of its idiopathic pulmonary fibrosis (IPF) drug with a second phase 3 win in a related lung disease leading the drugmaker to expand the indications it ...

Insmed Incorporated INSM announced that the FDA has accepted its new drug application (“NDA”) seeking approval of its ...

Feb. 6, 2025 — Despite new medication, cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease causes changes in the immune system early in life ...

A new study found that the proportion of people being diagnosed with lung cancer who have never smoked is increasing, and air ...

Long-term exposure to PM2.5, PM10, NO2 and ozone (O3) air pollution is associated with more hospital admissions for lower respiratory tract infections in adults.

A recent outbreak of various respiratory diseases has been spreading throughout West Texas. This includes COVID-19, influenza ...

The biggest challenge in training the next generation of respiratory therapists is getting them to engage in "critical ...

Respiratory illnesses like influenza, COVID-19 and respiratory syncytial virus (RSV) are leading to many people being ...